INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

1,241 studies · page 4 of 52

2017 / Systematic review and meta-analysis

High adherence to a Mediterranean diet was linked to reduced cancer mortality and lower risks of several cancer types.

An updated systematic review and meta-analysis of 83 studies (2,130,753 subjects) evaluated adherence to a Mediterranean diet (MedD) and cancer outcomes. Highest adherence was inversely associated with cancer mortality (RRcohort: 0.86, 95% CI 0.81-0.91), colorectal cancer (RRobservational: 0.82, 95% CI 0.75-0.88), breast cancer (RRRCT: 0.43, 95% CI 0.21-0.88; RRobservational: 0.92, 95% CI 0.87-0.96), gastric cancer (RR: 0.72), liver cancer (RR: 0.58), head and neck cancer (RR: 0.49), and prostate cancer (RR: 0.96). Among cancer survivors, associations with cancer mortality and recurrence were not statistically significant. Protective effects appeared most attributable to fruits, vegetables, and whole grains.

Shows an association, not proof of cause and effect.

Schwingshackl L, Schwedhelm C, Galbete C, et al. Nutrients, 2017. PMID 28954418

2017 / Umbrella review of meta-analyses

Coffee consumption was linked to lower risks of all-cause mortality, cardiovascular disease, and cancer, though pregnancy harms were observed.

An umbrella review analyzed 201 meta-analyses of observational studies and 17 meta-analyses of interventional studies on coffee and multiple health outcomes. Intakes of 3 to 4 cups a day versus none showed the largest relative risk reductions for all-cause mortality (RR 0.83, 95% CI 0.79 to 0.88), cardiovascular mortality (RR 0.81, 95% CI 0.72 to 0.90), and cardiovascular disease (RR 0.85, 95% CI 0.80 to 0.90). High versus low intake was linked to lower incident cancer risk (RR 0.82, 95% CI 0.74 to 0.89) alongside lower risk of neurological, metabolic, and liver conditions. Conversely, high consumption during pregnancy was linked to higher risk of low birth weight (OR 1.31), preterm birth, and pregnancy loss, and coffee was associated with fracture risk in women.

Shows an association, not proof of cause and effect.

Poole R, Kennedy OJ, Roderick P, et al. BMJ, 2017. PMID 29167102

2016 / Meta-analysis of observational studies

Obesity shows a weak link with cervical cancer, while overweight does not

A meta-analysis of nine observational reports with 128,233 participants evaluated body mass index and cervical malignancy. Overweight status was not linked to risk in case-control studies (OR: 1.03, 95% CI: 0.81, 1.25) but showed a slight relationship in cohort studies (OR: 1.10, 95% CI: 1.03, 1.17). Obesity had an estimated association of 1.40 (95% CI: 1.08, 1.71) in case-control and 1.08 (95% CI: 0.60, 1.52) in cohort designs.

Shows an association, not proof of cause and effect.

Poorolajal J, Jenabi E Eur J Cancer Prev, 2016. PMID 25932869

2016 / Pooled analysis of 15 prospective cohort studies

In a pooled cohort analysis, higher poultry intake was linked to lower fatal prostate cancer risk, while higher egg intake was linked to higher risk.

Researchers pooled data from 15 cohort studies involving 842,149 men to examine associations between intake of meat, poultry, seafood, and eggs and prostate cancer risk. Results did not support a substantial effect of total, unprocessed red, or processed meat for all prostate cancer outcomes, except a modest positive association for advanced stage tumors at diagnosis, and no substantial effect was observed for seafood. Poultry intake (≥45 vs. <5 g/day) was inversely associated with advanced (MVRR 0.83, 95% CI 0.70-0.99) and fatal prostate cancers (MVRR 0.69, 95% CI 0.59-0.82). Conversely, egg intake of ≥25 versus <5 g/day was associated with a 14% increased risk of advanced (MVRR 1.14, 95% CI 1.01-1.28) and fatal cancers (MVRR 1.14, 95% CI 1.00-1.30).

Shows an association, not proof of cause and effect.

Wu K, Spiegelman D, Hou T, et al. Int J Cancer, 2016. PMID 26685908

2016 / Meta-analysis of observational studies

Red meat intake was linked to a higher risk of non-Hodgkin lymphoma, while fish and seafood intake was inversely associated with multiple myeloma risk.

A meta-analysis of 33 observational studies examined the association between foods of animal origin and hematological cancers among adults. Red meat intake was associated with an increased risk of non-Hodgkin lymphoma (SRR 1.22, 95% CI 1.03-1.44, I2=35%). Fish and seafood intake was inversely associated with multiple myeloma risk (SRR 0.71, 95% CI 0.51-1.00, I2=82%), though between-study heterogeneity was high. Dairy intake showed a borderline positive association with non-Hodgkin lymphoma risk (SRR 1.26, 95% CI 0.99-1.60, I2=49%).

Shows an association, not proof of cause and effect.

Caini S, Masala G, Gnagnarella P, et al. Crit Rev Oncol Hematol, 2016. PMID 26921971

2016 / Systematic review and dose-response meta-analysis

Dietary cholesterol intake is associated with a modestly increased risk of endometrial cancer

A dose-response meta-analysis of one cohort and nine case-control studies investigated dietary cholesterol and endometrial cancer. Each 100 mg per day increase in cholesterol intake was associated with a 6% higher risk of endometrial cancer (OR = 1.06, 95% CI = 1.00-1.12), with marked heterogeneity (I2 = 64.2%). When restricted to case-control studies, the positive association remained significant (OR = 1.07, 95% CI = 1.01-1.13).

Gong TT, Li D, Wu QJ, et al. Oncotarget, 2016. PMID 26959738

2016 / Meta-analysis of observational studies

High red meat intake was weakly linked to increased NHL risk overall, but evidence was mixed and driven by case-control studies.

A meta-analysis of 14 observational studies (10,121 cases) evaluated the link between red and processed meat intake and NHL risk. Comparing the highest versus lowest consumption categories, the relative risk of NHL was 1.14 (95% CI 1.03, 1.26) for red meat and 1.06 (95% CI 0.98, 1.15) for processed meat. Significant associations appeared only in case-control studies, not cohort studies, and no significant links were seen for major histological subtypes. In an eight-study dose-response analysis, risk increased nonlinearly with daily red meat intake, though researchers concluded evidence was mixed, inconclusive, and affected by heterogeneity.

Shows an association, not proof of cause and effect.

Solimini AG, Lombardi AM, Palazzo C, et al. Cancer Causes Control, 2016. PMID 27076059

2016 / Systematic review and population-attributable fraction analysis

Alcohol consumption, even at light levels, is linked to higher breast cancer risk.

A critical review evaluated 15 meta-analyses alongside global health databases to examine alcohol use and breast cancer risk. Thirteen of the 15 meta-analyses showed a dose-response association between alcohol intake and breast cancer risk. Globally in 2012, an estimated 144,000 breast cancer cases (95% CI: 88,000 to 200,000) and 38,000 breast cancer deaths (95% CI: 2,400 to 53,000) were linked to alcohol, with 18.8% of cases occurring in light drinkers.

Shield KD, Soerjomataram I, Rehm J Alcohol Clin Exp Res, 2016. PMID 27130687

2016 / Systematic review and meta-analysis of observational studies

Soy isoflavone consumption was linked to a reduced risk of colorectal cancer, especially among Asian populations and in case-control studies.

A systematic review and meta-analysis of 17 epidemiologic studies (13 case-control and 4 prospective cohort studies) examined the association between soy isoflavone intake and colorectal cancer (CRC) risk. Soy isoflavone consumption was associated with reduced CRC risk (RR: 0.78, 95% CI: 0.72-0.85; I2 = 34.1%, P = 0.024). Subgroup analyses showed significant reductions for soy foods/products (RR: 0.79, 95% CI: 0.69-0.89), in Asian populations (RR: 0.79, 95% CI: 0.72-0.87), and in case-control studies (RR: 0.76, 95% CI: 0.68-0.84). The authors noted that other factors may affect this association due to the limited number of studies.

Shows an association, not proof of cause and effect.

Yu Y, Jing X, Li H, et al. Sci Rep, 2016. PMID 27170217

2016 / Meta-analysis of prospective cohort studies

Higher whole grain intake was linked to lower risks of total, cardiovascular, and cancer mortality in a meta-analysis of prospective cohorts.

A meta-analysis evaluated 14 prospective cohort studies comprising 786,076 participants with 97,867 total deaths, 23,957 CVD deaths, and 37,492 cancer deaths. Comparing extreme categories (high vs. low intake), pooled relative risks were 0.84 (95% CI, 0.80-0.88) for total mortality, 0.82 (95% CI, 0.79-0.85) for CVD mortality, and 0.88 (95% CI, 0.83-0.94) for cancer mortality. Dose-response analysis demonstrated monotonic associations, where each 16-g/d increase in whole grains was associated with relative risks of 0.93 (95% CI, 0.92-0.94) for total mortality, 0.91 (95% CI, 0.90-0.93) for CVD mortality, and 0.95 (95% CI, 0.94-0.96) for cancer mortality.

Shows an association, not proof of cause and effect.

Zong G, Gao A, Hu FB, et al. Circulation, 2016. PMID 27297341

2016 / Dose-response meta-analysis of prospective studies

Higher whole grain intake was linked to lower risks of cardiovascular disease, total cancer, and all-cause mortality in prospective studies.

A systematic review and dose-response meta-analysis evaluated 45 prospective studies examining whole grain consumption and disease or mortality risks. A 90 g/day increase in whole grain intake was associated with a lower relative risk of coronary heart disease (RR 0.81, 95% CI 0.75 to 0.87), cardiovascular disease (RR 0.78, 95% CI 0.73 to 0.85), total cancer mortality (RR 0.85, 95% CI 0.80 to 0.91), and all-cause mortality (RR 0.83, 95% CI 0.77 to 0.90). Risk reductions were also seen for respiratory, infectious, and all non-cardiovascular non-cancer mortality, with risk reductions seen up to 210-225 g/day for most outcomes. Little evidence of an association was found for refined grains, white rice, total rice, or total grains.

Shows an association, not proof of cause and effect.

Aune D, Keum N, Giovannucci E, et al. BMJ, 2016. PMID 27301975

2016 / Meta-analysis of observational studies

Higher dietary cholesterol intake is associated with an increased risk of breast cancer.

A meta-analysis evaluated 9 observational articles (6 cohort studies and 3 case-control studies) regarding dietary cholesterol intake and breast cancer. The pooled relative risk for the highest versus lowest cholesterol intake was 1.29 (95% CI: 1.06-1.56). Dose-response modeling identified a nonlinear relationship, with the positive association reaching statistical significance when cholesterol intake exceeded 370 mg/d.

Shows an association, not proof of cause and effect.

Li C, Yang L, Zhang D, et al. Nutr Res, 2016. PMID 27333953

2016 / Cumulative meta-analysis of randomized controlled trials

Vitamin B supplementation did not alter overall cancer incidence or total mortality.

A meta-analysis of 18 randomized controlled trials with 74,498 participants evaluated vitamin B supplementation. Supplements did not affect cancer incidence (RR 1.04, 95% CI: 0.98 to 1.10), cancer mortality (RR 1.05, 95% CI: 0.90 to 1.22), or all-cause mortality (RR 1.00, 95% CI: 0.94 to 1.06). When evaluating individual malignancies, supplementation lowered the occurrence of skin melanoma (RR 0.47, 95% CI: 0.23 to 0.94).

Zhang SL, Chen TS, Ma CY, et al. Medicine (Baltimore), 2016. PMID 27495015

2016 / Dose-response meta-analysis of prospective studies

Higher nut intake was linked to lower risks of cardiovascular disease, total cancer, all-cause mortality, and several cause-specific mortalities.

A systematic review and dose-response meta-analysis evaluated 20 prospective studies examining nut consumption and mortality outcomes in adults. A 28 g/day increase in nut intake was associated with reduced risk of coronary heart disease (RR 0.71, 95% CI: 0.63-0.80), cardiovascular disease (RR 0.79, 95% CI: 0.70-0.88), total cancer (RR 0.85, 95% CI: 0.76-0.94), and all-cause mortality (RR 0.78, 95% CI: 0.72-0.84). Inverse associations were also observed for mortality from respiratory disease (RR 0.48), diabetes (RR 0.61), and infectious disease (RR 0.25), with similar findings for tree nuts and peanuts.

Shows an association, not proof of cause and effect.

Aune D, Keum N, Giovannucci E, et al. BMC Med, 2016. PMID 27916000

2016 / Systematic review and meta-analysis of prospective cohort studies

Whole-grain intake was associated with lower all-cause, cardiovascular, and cancer mortality.

A meta-analysis of 20 prospective cohort studies tracked 2,282,603 participants over 5.5 to 26 years, recording 191,979 deaths. An extra three daily servings (90 g/d) of total whole grains was associated with lower all-cause mortality (RR 0.83; 95% CI: 0.79, 0.88) and a 25% lower risk of cardiovascular mortality. Whole-grain consumption was also inversely associated with total cancer mortality (RR 0.94; 95% CI: 0.91, 0.98).

Shows an association, not proof of cause and effect.

Benisi-Kohansal S, Saneei P, Salehi-Marzijarani M, et al. Adv Nutr, 2016. PMID 28140323

2015 / Meta-analysis of observational studies

High egg intake was linked to a significantly increased risk of ovarian cancer in a meta-analysis of observational studies.

A meta-analysis of 12 observational studies (six case-control and six cohort studies) including 629,453 participants and 3,728 ovarian cancer cases assessed the link between egg intake and ovarian cancer risk. High egg intake compared with the lowest category was associated with an increased risk of ovarian cancer (RR = 1.21, 95% CI [1.06, 1.38]). In subgroup analyses by study type, the association was statistically significant in case-control studies (RR = 1.22, 95% CI [1.03, 1.43]) but not in cohort studies (RR = 1.20, 95% CI [0.97, 1.48]).

Shows an association, not proof of cause and effect.

Zeng ST, Guo L, Liu SK, et al. Clin Nutr, 2015. PMID 25108572

2015 / Case-control study and meta-analysis of observational studies

Higher intake of allium vegetables, garlic, and onions was linked to lower gastric cancer risk, an association driven mainly by case-control studies.

Researchers evaluated allium vegetable intake and gastric cancer risk using an Italian case-control study (230 cases, 547 controls) and a meta-analysis (>10,000 cases). In the case-control study, odds ratios were 0.59 (95% CI, 0.25-1.41) for ≥2 portions of onion per week, 0.69 (95% CI, 0.41-1.15) for high garlic intake, and 0.70 (95% CI, 0.39-1.28) for frequent use of both. In the meta-analysis, pooled relative risks for highest versus lowest intake were 0.78 (95% CI, 0.67-0.91) for allium vegetables, 0.60 (95% CI, 0.47-0.76) for garlic, and 0.55 (95% CI, 0.41-0.73) for onion. However, the pooled relative risk for high allium vegetable intake from the four cohort studies was 1.02 (95% CI, 0.88-1.18), with authors noting further data from large cohorts are desirable.

Shows an association, not proof of cause and effect.

Turati F, Pelucchi C, Guercio V, et al. Mol Nutr Food Res, 2015. PMID 25215621

2015 / Meta-analysis of case-control, cohort, and randomized studies

Garlic intake was associated with a reduced risk of gastric cancer.

A meta-analysis of 14 case-control, two randomized, and one cohort study assessed garlic intake and gastric cancer risk among 8,621 cases and 14,889 controls. High garlic consumption was associated with lower gastric cancer risk (OR 0.49, 95% CI 0.38-0.62), as were low intake (OR 0.75, 95% CI 0.58-0.97) and any intake (OR 0.77, 95% CI 0.60-1.00). Substantial variation was observed in intake duration and exposure definitions across studies.

Kodali RT, Eslick GD Nutr Cancer, 2015. PMID 25411831

2015 / Dose-response meta-analysis

Heavy alcohol intake was linked to higher risk across multiple cancer types.

A meta-analysis evaluated 572 studies with 486,538 cancer cases across 23 malignancies. Compared to non- or occasional drinkers, heavy drinkers had higher risks for oral and pharyngeal cancer (RR 5.13), esophageal squamous cell carcinoma (RR 4.95), larynx (RR 2.65), gallbladder (RR 2.64), liver (RR 2.07), breast (RR 1.61), colorectum (RR 1.44), stomach (RR 1.21), pancreas (RR 1.19), and lung cancer (RR 1.15). Inverse associations were observed for Hodgkin's and non-Hodgkin's lymphomas.

Bagnardi V, Rota M, Botteri E, et al. Br J Cancer, 2015. PMID 25422909

2015 / Meta-analysis of prospective cohort studies

Dairy and dietary calcium intakes were linked to higher prostate cancer risk.

A meta-analysis of 32 prospective cohort studies evaluated dairy and calcium consumption in relation to prostate cancer. Greater risk was associated with total dairy (summary RR: 1.07; 95% CI: 1.02, 1.12 per 400 g/d), cheese (summary RR: 1.09; 95% CI: 1.02, 1.18 per 50 g/d), and dietary calcium (summary RR: 1.05; 95% CI: 1.02, 1.09 per 400 mg/d). Total and dairy calcium were also linked to increased risk, but nondairy calcium was not.

Shows an association, not proof of cause and effect.

Aune D, Navarro Rosenblatt DA, Chan DS, et al. Am J Clin Nutr, 2015. PMID 25527754

2015 / Meta-analysis

Higher serum 25-hydroxyvitamin D concentrations were associated with lower mortality in colorectal cancer patients.

A meta-analysis using a random-effects model evaluated the relationship between serum 25(OH)D concentrations at diagnosis and mortality in colorectal cancer patients. Patients in the highest quintile of 25(OH)D had 37% lower mortality compared to those in the lowest quintile (pooled odds ratio = 0.63, p < 0.0001). Dose-response curves showed lower hazard ratios for mortality with higher serum 25(OH)D through at least 40 ng/ml without exception. The authors noted that additional studies are needed to evaluate confounding or the possibility of reverse causation.

Shows an association, not proof of cause and effect.

Mohr SB, Gorham ED, Kim J, et al. J Steroid Biochem Mol Biol, 2015. PMID 25533386

2015 / Meta-analysis of observational studies

Higher dietary cholesterol intake was associated with increased pancreatic cancer risk

A meta-analysis of 16 articles including 4,513 pancreatic cancer cases evaluated the relationship between cholesterol consumption and disease risk. Higher cholesterol intake was associated with a higher risk of pancreatic cancer (summary RR 1.371, 95% CI 1.155-1.627), especially in America (summary RR 1.302, 95% CI 1.090-1.556). Linear dose-response modeling indicated that risk was linked to an 8% increase per 100 mg/day increment of dietary cholesterol (summary RR 1.08, 95% CI 1.04-1.13).

Shows an association, not proof of cause and effect.

Chen H, Qin S, Wang M, et al. Sci Rep, 2015. PMID 25649888

2015 / Meta-analysis of 17 cohort studies

Obesity was linked to an increased risk of aggressive prostate cancer and prostate cancer-associated mortality in a meta-analysis of cohort studies.

A meta-analysis of 17 cohort studies comprising 3,569,926 individuals evaluated the correlation between obesity and prostate cancer (PCa) incidence and mortality. Obesity was not significantly correlated with overall PCa incidence (RR, 1.00; 95% CI, 0.95-1.06). However, obesity was significantly associated with an increased risk of aggressive PCa (RR, 1.14; 95% CI, 1.04-1.25) and PCa-associated mortality (RR, 1.24; 95% CI, 1.15-2.33), with no heterogeneity across studies (I2=0.0%; P=0.847).

Shows an association, not proof of cause and effect.

Zhang X, Zhou G, Sun B, et al. Oncol Lett, 2015. PMID 25663903

2015 / Meta-analysis of prospective cohort studies

High diet quality indices were linked to lower mortality, cardiovascular disease, cancer, and diabetes.

A meta-analysis evaluated 15 prospective cohorts encompassing 1,020,642 participants. Top-tier adherence to HEI, AHEI, or DASH was associated with lower total mortality (RR 0.78, 95% CI 0.76 to 0.80), cardiovascular events or death (RR 0.78, 95% CI 0.75 to 0.81), malignancies (RR 0.85, 95% CI 0.82 to 0.88), and type 2 diabetes (RR 0.78, 95% CI 0.72 to 0.85). Neurodegenerative conditions showed no significant relationship.

Shows an association, not proof of cause and effect.

Schwingshackl L, Hoffmann G J Acad Nutr Diet, 2015. PMID 25680825